Skip to main content
. 2021 Jan 7;16(1):e0245284. doi: 10.1371/journal.pone.0245284

Table 4. Clinical characteristics of patients with DIIP (1).

No. Age Sex BMI Disease duration
(year)
Smoking type of Ps Baseline KL-6 levels
(U/ml)
underlying IP prior biologic Causative
biologic of DIIP
1 64 F 27.4 1 - PsV 2149 + - UST
2 75 M 19.5 30 + PsV 467 + - UST
3 65 M 25.1 6 + PsV 829 - IFX UST
4 79 M 21.3 22 + PsV 332 + SEC GUS
5 77 M 21.3 20 + PsV 561 + UST SEC
6 56 F 25.2 39 - PsA 1715 - ADA SEC